DABUR - Dabur India Ltd. Share Price

In the Q1 FY 2025-26 earnings conference call, Dabur India Limited's management expressed an optimistic outlook for the company despite facing challenges due to unseasonal rainfall and geopolitical issues. They indicated that the rural markets in India continue to outperform urban markets, a trend sustained for five consecutive quarters.

Key forward-looking points include:

1. Revenue Growth: Consolidated sales growth was reported at 1.7%, with a higher 7% growth when excluding the impacted seasonal portfolio. The domestic business revenue grew by 4.3% when excluding seasonality. For the upcoming quarters, management expects double-digit growth, particularly in most product categories besides beverages, which they forecast to have low single-digit growth due to recent weather conditions.

2. International Growth: The international business achieved robust growth of 13.7% in constant currency terms. Significant growth was noted across various regions: 10% in MENA, 20% in Sub-Saharan Africa, and around 30% in the United States.

3. Market Share: Dabur reported market share gains across 95% of its product portfolio during the quarter. Specific categories, such as Hair Oil and Home Care, saw substantial market share improvements.

4. Healthcare and Product Innovation: The healthcare segment, particularly Chyawanprash and Honey, showed strong growth, with Chyawanprash growing by 28% and Honey rising by 11%. New product formats are being actively developed to cater to modern consumer preferences.

5. Expense Management: The company reported maintaining its operating margins, despite inflationary pressures, by taking price increases and implementing cost-saving initiatives. Management aims for operating margins to improve significantly over the fiscal year.

6. Future Strategy: Management emphasized a focused strategy on core brands, market share expansion, and premiumization of offerings. They will explore M&A opportunities in wellness and health segments to bolster growth.

Overall, the management's approach underlines confidence in sustained growth and a robust recovery trajectory moving forward.

Here are the major questions asked during the earnings call along with detailed respective answers in first person:

Question 1: Mihir Shah from Nomura asked about the changes in disclosures and if the company could revert back to previous standards for better insights. He also inquired if one should expect high-teens growth in Q2 considering the favorable base from last year.

Answer: Yes, Mihir, regarding the disclosures, we've streamlined some presentations based on industry benchmarks to avoid competitive sensitivity. We remain committed to transparency and will keep sharing meaningful insights. As for growth, you're correct that last year's base was lower due to inventory corrections. We're anticipating double-digit growth in Q2, contingent on market conditions. Our juice division, unfortunately, is expected to show low single-digit growth due to recent weather patterns.

Question 2: Mihir Shah also asked about margin pressures, specifically regarding gross margins and inflation's impact.

Answer: We don't foresee margin pressures. Previous inflation was around 7%, and we managed it through a combination of price increases of about 3%-4% and savings initiatives. The projection for inflation is around 8% going forward, but we are optimistic about mitigating this with our strategies. Thus, we maintain our gross margin strength despite external pressures, as indicated by consistent operating margin levels.

Question 3: Mihir Shah questioned the advertising spending, noting a decline, and whether that would be a one-off or if ad spends would increase in the future.

Answer: Our ad and promotion expenses actually increased by about 5% despite a lower spend on media. We redirected funds towards consumer trade investments instead. There are no one-off effects to worry about; we plan to invest more in advertising going forward to enhance our brand and distribution investments.

Question 4: Prakash Kapadia from Kapadia Financial Services asked about long-term growth challenges in the Healthcare segment, focusing on honey and Chyawanprash.

Answer: The challenges this quarter stemmed from a significant 30% drop in glucose sales due to weather. However, brands like Chyawanprash achieved 30% growth, and honey saw 11% growth. Our new formats contribute significantly, and we believe they resonate well with consumers. We expect these segments will continue to perform strongly, despite the focus on overcoming short-term weather-related setbacks.

Question 5: Aditya Vikram from Digital Securities inquired about the company's overall growth guidance moving forward.

Answer: For the full year, we are targeting high single-digit growth, anticipating double-digit growth in the upcoming quarter. While beverages may face some pressure resulting in low single-digit growth, other segments should perform well due to both urban and rural market trends. Overall, we strive to ensure strong market share gains across our categories.

Question 6: Tejas Shah asked about the strategic framework guiding portfolio adjustments for the next few years.

Answer: We recently conducted a vision exercise and identified several strategic moves. These include doubling down on our core brands, targeting higher growth through premiumization, and streamlining our Healthcare portfolio. Additionally, we are scouting for mergers and acquisitions to enhance our existing categories. Overall, we plan to focus on Oral Care, Home Care, and Health Juices to drive future growth.

Question 7: Gaurang Kakkad questioned the volume growth supporting the reported numbers.

Answer: Excluding seasonal impact, our volume growth is approximately 3%-3.5%. This reflects our underlying performance without the interference from less favorable market conditions in our seasonal segments.

Each answer remains concise while delivering key insights about the company's performance and strategy.